Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 6Observational 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 3Urinary Bladder Neoplasms 2Sarcoma 2Prostatic Neoplasms 2Pancreatic Cyst 2Neoplasms 2Melanoma 2Stomach Neoplasms 1Stage IB Cervical Cancer FIGO 2018 1Spondylitis, Ankylosing 1Psoriasis 1Papillomavirus Infections 1Pancreatic Neoplasms 1Pancreatic Diseases 1Ovarian Neoplasms 1Neoplasm Metastasis 1Lupus Erythematosus, Systemic 1Kidney Neoplasms 1Inflammatory Bowel Diseases 1Hepatitis B, Chronic 1Giant Cell Tumor of Bone 1Crohn Disease 1Colitis, Ulcerative 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Bone Neoplasms 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Arthritis, Reactive 1

Interventions

Surveys and Questionnaires 9Cystectomy 6Blood Specimen Collection 5Neoadjuvant Therapy 4Cystoscopy 4Drug Therapy 3avelumab 2Urination 2Urinary Diversion 2Surgical Procedures, Operative 2Radiotherapy 2Pioglitazone 2Microarray Analysis 2Methods 2Magnetic Resonance Spectroscopy 2Interviews as Topic 2Immunohistochemistry 2Defecation 2Biopsy 25-aminolevulinic acid hexyl ester 2trastuzumab deruxtecan 1sargramostim 1pembrolizumab 1erdafitinib 1enfortumab vedotin 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Watchful Waiting 1Urinary Sediment Analysis 1Therapeutics 1Specimen Handling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Urinary Bladder Neoplasms × Methods × Clear all
NCT02811952 2022-10-14

Measuring Urinary Nano Particles and Metallic Compounds in TCC Patients

Carmel Medical Center

Completed
100 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT02298998 2021-06-14

Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study

The University of Texas Health Science Center at San Antonio

Completed
41 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡